DEF 14A
DEF 14A SPECIAL MEETING PROXY 2017
- Company
- Arbutus Biopharma Corp
- Filed
- December 6, 2017
- Period of Report
- December 6, 2017
- Accession Number
- 0001628280-17-012143
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →